TrialClinical cancer research : an official journal of the American Association for Cancer Research2012

Phase II study of single-agent navitoclax (ABT-263) and biomarker correlates in patients with relapsed small cell lung cancer.

Charles M Rudin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.